デフォルト表紙
市場調査レポート
商品コード
993540

局所麻酔薬の世界市場

Local Anesthesia Drugs

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 283 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.27円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

局所麻酔薬の世界市場
出版日: 2021年04月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 283 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の局所麻酔薬の市場規模は、分析期間(2020年~2027年)に3.7%のCAGRで成長する見通しで、2020年の52億米ドルから、2027年には67億米ドルに達すると予測されています。

当レポートで分析されているセグメントの1つであるリドカインは、分析期間中に4%のCAGRで成長し、26億米ドルに達すると予測されています。

当レポートは、世界の局所麻酔薬市場について調査しており、市場シェア、Covid-19の影響、動向や成長要因、地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

調査対象企業の例

  • Aspen Pharmacare
  • Fresenius SE & Co. KGaA
  • Mylan
  • Pacira Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Pierrel group
  • Sagent Pharmaceutical, Inc.
  • Teva Pharmaceuticals

目次

I. 調査手法

II. エグゼクティブサマリー

  • 市場概要
    • インフルエンサー市場の洞察
    • 世界市場の軌跡
    • Covid-19の影響と迫り来る世界の景気後退
  • 主要企業
  • 動向と推進要因
  • 世界市場の見通し

III. 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

IV. 競合

  • 企業プロファイル:43社
目次
Product Code: MCP22171

Abstract:

Global Local Anesthesia Drugs Market to Reach $6.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Local Anesthesia Drugs estimated at US$5.2 Billion in the year 2020, is projected to reach a revised size of US$6.7 Billion by 2027, growing at a CAGR of 3.7% over the analysis period 2020-2027. Lidocaine, one of the segments analyzed in the report, is projected to record a 4% CAGR and reach US$2.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bupivacaine segment is readjusted to a revised 3.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 5.9% CAGR

The Local Anesthesia Drugs market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2027 trailing a CAGR of 6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.2% and 2.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Ropivacaine Segment to Record 2.9% CAGR

In the global Ropivacaine segment, USA, Canada, Japan, China and Europe will drive the 2.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$541.6 Million in the year 2020 will reach a projected size of US$656.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$871.4 Million by the year 2027, while Latin America will expand at a 3.1% CAGR through the analysis period.

Select Competitors (Total 43 Featured) -

  • Aspen Pharmacare
  • Fresenius SE & Co. KGaA
  • Mylan
  • Pacira Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Pierrel group
  • Sagent Pharmaceutical, Inc.
  • Teva Pharmaceuticals

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Local Anesthesia Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Local Anesthesia Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Local Anesthesia Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Lidocaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Lidocaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Lidocaine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Bupivacaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Bupivacaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Bupivacaine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Ropivacaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Ropivacaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Ropivacaine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Prilocaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Prilocaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Prilocaine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Other Product Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Other Product Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Product Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Injectable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Injectable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Injectable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Surface Anesthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Surface Anesthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Surface Anesthetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 25: USA Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: USA 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 28: USA Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 31: Canada Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Canada Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: Canada 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 34: Canada Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Canada Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Canada 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 37: Japan Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Japan Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: Japan 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 40: Japan Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Japan Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: Japan 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 43: China Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: China Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: China 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 46: China Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: China Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: China 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 49: Europe Current & Future Analysis for Local Anesthesia Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe Historic Review for Local Anesthesia Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: Europe 15-Year Perspective for Local Anesthesia Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 52: Europe Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 55: Europe Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Europe Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: Europe 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 58: France Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: France Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: France 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 61: France Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: France Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: France 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 64: Germany Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Germany Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: Germany 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 67: Germany Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Germany Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: Germany 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 70: Italy Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Italy Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: Italy 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 73: Italy Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Italy Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: Italy 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 76: UK Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: UK Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: UK 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 79: UK Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: UK Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: UK 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 82: Spain Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Spain Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: Spain 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 85: Spain Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Spain Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: Spain 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 88: Russia Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Russia Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: Russia 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 91: Russia Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Russia Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: Russia 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 94: Rest of Europe Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Rest of Europe Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 96: Rest of Europe 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 97: Rest of Europe Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Rest of Europe Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 99: Rest of Europe 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 100: Asia-Pacific Current & Future Analysis for Local Anesthesia Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 101: Asia-Pacific Historic Review for Local Anesthesia Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 102: Asia-Pacific 15-Year Perspective for Local Anesthesia Drugs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 103: Asia-Pacific Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Asia-Pacific Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 105: Asia-Pacific 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 106: Asia-Pacific Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Asia-Pacific Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 108: Asia-Pacific 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 109: Australia Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Australia Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 111: Australia 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 112: Australia Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Australia Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 114: Australia 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 115: India Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 116: India Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 117: India 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 118: India Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 119: India Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 120: India 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 121: South Korea Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 122: South Korea Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 123: South Korea 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 124: South Korea Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 125: South Korea Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 126: South Korea 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 127: Rest of Asia-Pacific Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Rest of Asia-Pacific Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 129: Rest of Asia-Pacific 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 130: Rest of Asia-Pacific Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Rest of Asia-Pacific Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 132: Rest of Asia-Pacific 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 133: Latin America Current & Future Analysis for Local Anesthesia Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 134: Latin America Historic Review for Local Anesthesia Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 135: Latin America 15-Year Perspective for Local Anesthesia Drugs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 136: Latin America Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Latin America Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 138: Latin America 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 139: Latin America Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Latin America Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 141: Latin America 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 142: Argentina Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Argentina Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 144: Argentina 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 145: Argentina Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Argentina Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 147: Argentina 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 148: Brazil Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Brazil Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 150: Brazil 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 151: Brazil Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Brazil Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 153: Brazil 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 154: Mexico Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Mexico Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 156: Mexico 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 157: Mexico Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Mexico Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 159: Mexico 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 160: Rest of Latin America Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Rest of Latin America Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 162: Rest of Latin America 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 163: Rest of Latin America Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 164: Rest of Latin America Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 165: Rest of Latin America 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 166: Middle East Current & Future Analysis for Local Anesthesia Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 167: Middle East Historic Review for Local Anesthesia Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 168: Middle East 15-Year Perspective for Local Anesthesia Drugs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 169: Middle East Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 170: Middle East Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 171: Middle East 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 172: Middle East Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 173: Middle East Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 174: Middle East 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 175: Iran Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 176: Iran Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 177: Iran 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 178: Iran Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 179: Iran Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 180: Iran 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 181: Israel Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Israel Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 183: Israel 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 184: Israel Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Israel Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 186: Israel 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 187: Saudi Arabia Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Saudi Arabia Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 189: Saudi Arabia 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 190: Saudi Arabia Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Saudi Arabia Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 192: Saudi Arabia 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 193: UAE Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 194: UAE Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 195: UAE 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 196: UAE Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 197: UAE Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 198: UAE 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 199: Rest of Middle East Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Rest of Middle East Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 201: Rest of Middle East 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 202: Rest of Middle East Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Rest of Middle East Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 204: Rest of Middle East 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 205: Africa Current & Future Analysis for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Africa Historic Review for Local Anesthesia Drugs by Product Segment - Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 207: Africa 15-Year Perspective for Local Anesthesia Drugs by Product Segment - Percentage Breakdown of Value Sales for Lidocaine, Bupivacaine, Ropivacaine, Prilocaine and Other Product Segments for the Years 2012, 2020 & 2027
    • TABLE 208: Africa Current & Future Analysis for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Africa Historic Review for Local Anesthesia Drugs by Application - Injectable and Surface Anesthetic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 210: Africa 15-Year Perspective for Local Anesthesia Drugs by Application - Percentage Breakdown of Value Sales for Injectable and Surface Anesthetic for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 43